Patient flowchart. by Anna D. Ware (19688153)

“…Preexisting aspirin prescription was associated with a significant decrease risk of post-COVID-19 thromboembolic disorders, including pulmonary embolism (OR [95% CI]: 0.69 [0.65, 0.74]) and deep vein thrombosis (OR [95% CI]: 0.76 [0.69, 0.83], but an increased risk of acute arterial diseases, including ischemic stroke (OR [95% CI]: 1.54 [1.46, 1.60]) and acute ischemic heart disease (1.33 [1.26, 1.39]).…”

Oscillatory potential (OP) analysis of 6-, 9-, and 12-month ERGs shows continued dysfunction in the inner retina reflecting A- and B-wave results. by Shaylah McCool (20818280)

“…<p>(A) Example OP traces from C57 (black) and 5xFAD (blue) mice at 3 timepoints show significantly increased OP amplitudes in the 6-month 5xFAD mice and significantly decreased OP amplitudes in the 9-month 5xFAD mice. …”

PRISMA flowchart of the included studies. by Gaelle Salame (21077899)

“…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …”

Characteristics of Included Studies. by Gaelle Salame (21077899)

“…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …”

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

Table 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy cohort.docx by Yanyan Mao (1998469)

“…The modification displayed a quasi-U-shaped distribution in relation to BPA and decreased as TSH levels increased.…”

Presentation 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy coho... by Yanyan Mao (1998469)

“…The modification displayed a quasi-U-shaped distribution in relation to BPA and decreased as TSH levels increased.…”

Image 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy cohort.pdf by Yanyan Mao (1998469)

“…The modification displayed a quasi-U-shaped distribution in relation to BPA and decreased as TSH levels increased.…”

Supplementary file 1_Bupropion decreases plasma levels of asymmetric dimethylarginine and ameliorates renal injury by modulation of Ddah1, Oatp4c1, Oct2, and Mate1 in rats with ade... by Lulu Huang (469776)

“…EBUP (1 and 100 nmol/L) lowered LDH. BUP (100 nmol/L) and TBUP (1 μmol/L) decreased NAG. …”

(a) Taylor diagrams of Khandelwal et al. [13], Brabdas et al, Kumar et al. [12] models. (b) Taylor diagrams of Ranjbar-Karami et al. [14], Christaras et al. [52], Feng et al. [16],... by Fahd Saeed Alakbari (10701871)

Movement variability conditioned on task outcome. by Adam M. Roth (19845864)

Image 2_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”

Image 3_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”

Table 2_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.docx by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”

Table 10_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.xlsx by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”

Table 3_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.xlsx by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”

Table 7_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.doc by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”

Image 8_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”

Table 6_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.doc by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”

Table 8_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.xlsx by Yu Zhang (12946)

“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”